:max_bytes(150000):strip_icc()/GettyImages-2210967075-65cc5435f42c464b81e47d71710cc99f.jpg)
Palantir (PLTR) shares declined 9% to $158 following renewed short seller concerns from Citron Research's Andrew Left, who argues the stock is "detached from fundamentals" and overvalued, suggesting a $40 target despite its 2025 doubling driven by strong AI-platform sales. This valuation skepticism is widely shared among Wall Street analysts, with six of eight surveyed holding "hold" ratings and noting the stock may be "priced for perfection" and disconnected from even optimistic growth scenarios, signaling potential for further correction.
Palantir (PLTR) shares experienced a significant 9% decline to approximately $158 following a critical report from short-seller Citron Research, which posits the stock is "detached from fundamentals" and suggests a fair value of $40. This negative catalyst challenges the stock's prior momentum, where it had more than doubled in 2025 to become the S&P 500's best performer, driven by record sales from its Artificial Intelligence Platform. The valuation concern is not isolated to the short-seller; it reflects a broader sentiment among Wall Street analysts. Of eight analysts surveyed by Visible Alpha, six maintain "hold" ratings, with firms like Jefferies and HSBC echoing the view that the valuation is disconnected from even optimistic growth scenarios and is already "priced for perfection." This consensus suggests that despite strong underlying business performance in AI, the market's pricing of the stock has reached a level that institutional analysts find difficult to justify, increasing its vulnerability to a correction.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
-0.25
Ticker Sentiment